Loading...
1GSN logo

Novanta Inc.DB:1GSN Stock Report

Market Cap €4.0b
Share Price
€115.00
n/a
1Y-21.1%
7D-8.9%
Portfolio Value
View

Novanta Inc.

DB:1GSN Stock Report

Market Cap: €4.0b

Novanta (1GSN) Stock Overview

Provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. More details

1GSN fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends0/6

1GSN Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Novanta Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Novanta
Historical stock prices
Current Share PriceUS$112.00
52 Week HighUS$142.00
52 Week LowUS$84.50
Beta1.62
1 Month Change-2.61%
3 Month Change15.46%
1 Year Change-21.13%
3 Year Change-16.42%
5 Year Change6.67%
Change since IPO29,608.22%

Recent News & Updates

Recent updates

Shareholder Returns

1GSNDE ElectronicDE Market
7D-8.9%1.5%0.6%
1Y-21.1%5.6%6.6%

Return vs Industry: 1GSN underperformed the German Electronic industry which returned 4.6% over the past year.

Return vs Market: 1GSN underperformed the German Market which returned 5.4% over the past year.

Price Volatility

Is 1GSN's price volatile compared to industry and market?
1GSN volatility
1GSN Average Weekly Movement5.8%
Electronic Industry Average Movement6.2%
Market Average Movement5.5%
10% most volatile stocks in DE Market14.7%
10% least volatile stocks in DE Market2.6%

Stable Share Price: 1GSN has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: 1GSN's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19683,000Matthijs Glastrawww.novanta.com

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles.

Novanta Inc. Fundamentals Summary

How do Novanta's earnings and revenue compare to its market cap?
1GSN fundamental statistics
Market cap€4.03b
Earnings (TTM)€45.61m
Revenue (TTM)€830.86m
90.6x
P/E Ratio
5.0x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1GSN income statement (TTM)
RevenueUS$980.60m
Cost of RevenueUS$545.32m
Gross ProfitUS$435.28m
Other ExpensesUS$381.46m
EarningsUS$53.83m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)1.51
Gross Margin44.39%
Net Profit Margin5.49%
Debt/Equity Ratio19.1%

How did 1GSN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/26 22:26
End of Day Share Price 2026/02/26 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Novanta Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert MasonBaird
Andrew BuscagliaBerenberg
Lee JagodaCJS Securities, Inc.